NJ Alliance for Clinical and Translational Science (NJACTS) Symposium: Abstract Submission Deadline

Fri, Aug 6, 2021, 11:59 pm
Campus Community
Open to the Public
New Jersey Alliance for Clinical and Translational Science (NJACTS)

Researchers from Princeton, Rutgers and NJIT are invited to submit abstracts for the first annual symposium of the New Jersey Alliance for Clinical and Translational Science (NJACTS).

Abstract Submission

Abstracts will be reviewed by the session co-chairs. Two abstracts will be selected for presentations and others will be selected for the poster session.

Deadline: Abstracts must be submitted by August 6 at midnight, using the online form available at:

Symposium Abstract Submission Form      OR    Symposium Abstract Submission Form (Shortened Link).

The Symposium

Date: The symposium will be held virtually on September 22-23.

Attendance: Open to all, including faculty, postdocs, students, industry and medicine professionals and others.

Registration: Register early; space is limited: Symposium Registration Form  OR  Symposium Registration Form (Shortened).


The goal of the Symposium is to bring research from the NJ ACTS academic communities of Rutgers, Princeton and NJIT together to present the best new clinical and translational research and build collaborative partnerships.  

The two-day conference will feature sessions on four hot topics:

  • Inclusion, Diversity and Equity in AI and Machine Learning: Jonathan Cohen, David Foran and Yi Chen
    • Session #1 External Speaker
      Dr. Fei Wang, Associate Professor of Healthcare Policy and Research
      Weill Cornell Medicine and Associate Professor of Population Health Sciences, Population Health Sciences
  • Social and Environmental Determinants of Health in the Urban Setting: Shawna Hudson, Noreen Goldman and Helmut Zarbl
    • Session #2 External Speaker
      Dr. Olajide Williams, Professor of Neurology; Chief of Staff of Neurology; Associate Dean of Community Research and Engagement, New York-Presbyterian Columbia University Irving Medical Center
  • Clinical Trial Science after a Pandemic: Mark Einstein and Jeffrey Carson
    • Session #3 External Speaker
      Dean Fergossen, MHA, PhD, Professor, Departments of Medicine, Surgery, & the School of Epidemiology and Public Health, University of Ottawa
      Endowed Chair, Clinical Epidemiology Program
      Ottawa Hospital Research Institute/University of Ottawa
  • Biomarker Exploration in the Heterogeneity of Disease: David Alland, Martin Blaser and Jerrold Ellner
    • Session #4 External Speaker
      Eran Elinav, M.D., Ph.D., Weizman Institute, HHMI & the Bill and Melinda Gates Foundation International Research Scholar

Each session will include a keynote by an internationally recognized researcher and two presentations from within the NJ ACTS community. Additional NJ ACTS research will be presented at the poster session. There will be opportunities for networking, and for learning about the NJ ACTS cores and the resources and services they can provide.

Questions? Email NJACTS@rbhs.rutgers.edu